Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Fuji
Chubb
McKesson
Harvard Business School
Express Scripts
Teva
Fish and Richardson
Dow
Cantor Fitzgerald

Generated: December 12, 2017

DrugPatentWatch Database Preview

NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE Drug Profile

« Back to Dashboard

Which patents cover Neomycin And Polymyxin B Sulfates And Dexamethasone, and what generic alternatives are available?

Neomycin And Polymyxin B Sulfates And Dexamethasone is a drug marketed by Bausch And Lomb, Perrigo Co Tennessee, and Alcon Pharms Ltd. and is included in three NDAs.

The generic ingredient in NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE is dexamethasone; neomycin sulfate; polymyxin b sulfate. There are thirty-nine drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the dexamethasone; neomycin sulfate; polymyxin b sulfate profile page.

Summary for NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE

Drug patent expirations by year for NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE

Pharmacology for NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Bausch And LombNEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONEdexamethasone; neomycin sulfate; polymyxin b sulfateOINTMENT;OPHTHALMIC064063-001Jul 25, 1994ATRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Perrigo Co TennesseeNEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONEdexamethasone; neomycin sulfate; polymyxin b sulfateOINTMENT;OPHTHALMIC062938-001Jul 31, 1989ATRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Alcon Pharms LtdNEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONEdexamethasone; neomycin sulfate; polymyxin b sulfateSUSPENSION/DROPS;OPHTHALMIC062721-001Nov 17, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Argus Health
Novartis
Baxter
Harvard Business School
UBS
McKinsey
Moodys
Federal Trade Commission
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot